✦ LIBER ✦

Antitumor Activity of TZT-1027, a Novel Doiastatin 10 Derivative

✍ Scribed by Kobayashi, Motohiro ;Natsume, Tsugitaka ;Tamaoki, Satoru ;Watanabe, Jun-ichi ;Asano, Hajime ;Mikami, Takashi ;Miyasaka, Katsuhiko ;Miyazaki, Koichi ;Gondo, Masaaki ;Sakakibara, Kyoichi ;Tsukagoshi, Shigeru

Book ID: 108581414
Publisher: Wiley (Blackwell Publishing)
Year: 1997
Tongue: English
Weight: 654 KB
Volume: 88
Category: Article
ISSN: 0910-5050
DOI: 10.1111/j.1349-7006.1997.tb00383.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of TZT-1027, a novel synth

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer

✍ J. Horti; E. Juhasz; Z. Monostori; K. Maeda; S. Eckhardt; I. Bodrogi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 382 KB

Phase I study of TZT-1027, a novel synth

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, given weekly to advanced solid tumor patients for 3 weeks

✍ Nobuyuki Yamamoto; Masahiro Andoh; Masaaki Kawahara; Masahiro Fukuoka; Hisanobu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Antitumor activity on murine tumors of a

Antitumor activity on murine tumors of a novel antitumor benzoylphenylurea derivative, HO-221

✍ Tsunetaka Nakajima; Hirotoshi Masuda; Tadao Okamoto; Masahiro Watanabe; Kazumasa 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 511 KB

Increased effects of MPDAX, a novel xant

Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin

✍ Yasuyuki Sadzuka; Tomomi Sugiyama; Hirokazu Suzuki; Hiroyuki Sawanishi; Ken-ichi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

PS2-118 Interferon alpha enhances the an

PS2-118 Interferon alpha enhances the antitumor activity of a novel purine derivative drug

✍ Juan Antonio Marchal; M.A. García; A. Ramirez; E. Carrasco; H. Boulaiz; G. Jimen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phase I study of TZT-1027, a novel synth

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses

✍ Kenji Tamura; Kazuhiko Nakagawa; Takayasu Kurata; Taroh Satoh; Toshiji Nogami; K 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 342 KB